IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

about

IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q49710359

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

IDH2 is a Novel Diagnostic and Prognostic Serum Biomarker for Non-Small-Cell Lung Cancer.

@nl

IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

@en

type

Item

label

IDH2 is a Novel Diagnostic and Prognostic Serum Biomarker for Non-Small-Cell Lung Cancer.

@nl

IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

@en

prefLabel

IDH2 is a Novel Diagnostic and Prognostic Serum Biomarker for Non-Small-Cell Lung Cancer.

@nl

IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

@en

P1476

IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.

@en

P2093

Ann M Bode

http://www.w3.org/2001/XMLSchema#string

Baihua Zhang

http://www.w3.org/2001/XMLSchema#string

Chunfang Zhang

http://www.w3.org/2001/XMLSchema#string

Jiang-Jiang Li

http://www.w3.org/2001/XMLSchema#string

Min Tang

http://www.w3.org/2001/XMLSchema#string

Qianjin Liao

http://www.w3.org/2001/XMLSchema#string

Ruilei Li

http://www.w3.org/2001/XMLSchema#string

Shaohui Liu

http://www.w3.org/2001/XMLSchema#string

Shifang Peng

http://www.w3.org/2001/XMLSchema#string

Shuo You

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Benefits and harms of CT screening for lung cancer: a systematic review

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Cancer statistics, 2012

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon

Cancer statistics, 2016

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

American Cancer Society lung cancer screening guidelines.

P304

602-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12182

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29465809

http://www.w3.org/2001/XMLSchema#string

P932

5928355

http://www.w3.org/2001/XMLSchema#string